explore -WSS

explore

author：entertainment 2025-10-02 11:09:29 - browse：2

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： He's a Nobel laureate. Critics say he was misleading on Covid

Wikipedia

WSS

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Alabama frozen embryo ruling has major implications for IVF clinics

Obesity drugs seen as possible treatment for liver disease MASH

hotspot

explore

knowledge

In age of alternative facts, a scholarly course on calling out crap

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Psychedelics group wrestles with new pharma identity

Prescription digital therapeutics are key to pharma’s future

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

UpToDate has a racism problem: Dr. Stanley Goldfarb

Sports medicine is finally prioritizing gender equality

6 phony surgeries that take placebo to the extreme

ChatGPT in medicine: STAT answers readers' burning questions

Security flaws in third

leisure time

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Prescription digital therapeutics are key to pharma’s future

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

STAT readers on older presidents, polypills, Medicare, and more

STAT readers on older presidents, polypills, Medicare, and more

leisure time

focus

Wikipedia

hotspot